NCT05483166 is a NA clinical trial of ImPACT in Pediatric Cancer, sponsored by Aarhus University Hospital.

Who is sponsoring NCT05483166?

NCT05483166 is sponsored by Aarhus University Hospital.

What drugs are being tested in NCT05483166?

Interventions in NCT05483166: ImPACT.

What condition does NCT05483166 study?

NCT05483166 studies Pediatric Cancer, Cognitive Dysfunction.

Is NCT05483166 still recruiting?

NCT05483166 is currently recruiting now. Last updated 1 February 2024.

Last reviewed 2024-02-01 · How we verify

NCT05483166

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Engaging Parents in Neuropsychological Rehabilitation for Childhood Cancer Survivors: The ImPACT Program - A Pilot Study

Recruiting now NA Last updated 1 February 2024

What this trial tests

NA trial testing ImPACT in Pediatric Cancer in 10 participants. Currently enrolling.

Timeline

1 October 2022

Primary endpoint
1 June 2025

1 December 2026

Quick facts

Lead sponsor	Aarhus University Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	1 October 2022
Primary completion	1 June 2025
Estimated completion	1 December 2026
Sites	1 location across Denmark

Drugs / interventions tested

ImPACT — full drug profile →

Conditions studied

Pediatric Cancer — all drugs for Pediatric Cancer →
Cognitive Dysfunction — all drugs for Cognitive Dysfunction →

Sponsor

Aarhus University Hospital

Who can join

Adults 10 to 17, any sex, with Pediatric Cancer or Cognitive Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of a novel, context-sensitive neuropsychological rehabilitation intervention for childhood cancer survivors and their families.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ImPACT

Trials testing the same drug.

NCT03844282 — Research Evaluating Sports ConcUssion Events - Rapid Assessment of Concussion and Evidence for Return · completed
NCT02932228 — Evaluation of Intensive Management Patient Aligned Care Team · NA · completed

Other recruiting trials for Pediatric Cancer

Currently open trials in the same condition.

NCT07506239 — Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma · NA · recruiting
NCT07278778 — Cancer Care Companion · NA · recruiting
NCT07473518 — Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy · recruiting
NCT06939322 — LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study) · NA · recruiting
NCT07188311 — Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma · NA · recruiting

Other Aarhus University Hospital trials

Trials by the same sponsor.

NCT07432802 — Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer · NA · not yet recruiting
NCT07499336 — UNDERSTANDING THE T-CELL AND B-CELL RECEPTOR REPERTOIRE IN CHILDREN AND YOUNG ADULTS WITH ANTI-DRUG ANTIBODIES AGAINST P · not yet recruiting
NCT07454486 — TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cance · not yet recruiting
NCT07284069 — Senicapoc and Perampanel for Newly Diagnosed Glioblastoma · EARLY_PHASE1 · recruiting
NCT07426250 — Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05483166 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aarhus University Hospital
Last refreshed: 1 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483166.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing